How Can Prefabricated Membranes Load Ascorbic Acid Can Curtail Gingival Recession?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-17

Study Completion Date

2025-10-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontal diseases are a prevalent issue, often leading to gingival recession, where the gingival margin recedes, exposing the tooth root and causing various problems. Gingival recession can be managed through both non-surgical and surgical interventions The non-surgical approach often involves plaque control and addressing any underlying inflammatory conditions. However, in cases of advanced recession, surgical treatment may be necessary Several treatment techniques have been proposed, which can be divided into pedicle and free grafts. The latter can also be classified as free gingival grafts (FGG) or as connective tissue grafts (CTG). Other treatment options include soft tissue substitutes or regenerative therapies Harvesting graft from the palate has several problems, such as pain, inflammation, bleeding, flap necrosis, and infection at the donor site. For this reason, we need a substitute for soft tissue graft harvesting Carbopol polymers, also known as carbomers, are widely utilized in pharmaceutical formulations for their excellent mucoadhesive properties. This high molecular weight, cross-linked acrylic acid polymers are particularly effective in enhancing the adhesion of formulations to mucosal surfaces, thereby improving drug delivery and bioavailability

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Antioxidant Dentifrice on Gingivitis

NCT02102295

Gingivitis

COMPLETED PHASE3

Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults

NCT04658225

Age Problem

COMPLETED NA

Comparison of 0.12% Chlorhexidine and MicroRepair ABX Mouthwash in Gingivitis Management

NCT07088653

Gingivitis Dental Plaque Gingival Inflammation

RECRUITING NA

0.2% Chlorhexidine vs MicroRepair ABX in Gingivitis

NCT07088666

Gingivitis and Periodontal Diseases Dental Plaque Oral Hygiene

RECRUITING NA

The Influence of Rumex Acetosa L on the Intraoral Colonization With Porphyromonas Gingivalis

NCT02039648

Periodontitis

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gingival recession is a common finding in daily clinical practice. Several issues may be associated with the apical shift of the gingival margin such as dentine hypersensitivity, root caries, non-carious cervical lesions (NCCLs), and compromised aesthetics. The first step in an effective management and prevention program is to identify susceptibility factors and modifiable conditions associated with gingival recession. Non-surgical treatment options for gingival recession defects include establishing optimal plaque control, removing overhanging subgingival restorations, behavior change interventions, and using desensitizing agents. In cases where a surgical approach is indicated, coronally advanced flap and tunneling procedures combined with a connective tissue graft are considered the most predictable treatment options for single and multiple recession defects. If there is a contraindication for harvesting a connective tissue graft from the palate or the patient wants to avoid a donor site surgery, adjunctive use of acellular dermal matrices, collagen matrices, and/or enamel matrix derivatives can be a valuable treatment alternative. For gingival recession defects associated with NCCLs a combined restorative-surgical approach can provide favourable clinical outcomes. If a patient refuses a surgical intervention or there are other contraindications for an invasive approach, gingival conditions should be maintained with preventive measures. This paper gives a concise review of when and how to treat gingival recession defects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingival Recession, Localized Gingival Diseases Recession, Gingival

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Inclusion criteria:

1. Patients of both genders with ages more than 18 years.
2. At least two adjacent teeth in maxillary or mandibular anterior sextant with Cairo classification (RT1 or RT 2) labial GR defect.
3. Good general health with no contraindications for periodontal surgery (American Society of Anesthesiologists I).
4. Non-smoker patients.

Exclusion criteria:

1. Pregnant and lactating women.
2. Mal alignment teeth.
3. Patients under active orthodontic therapy.
4. Periodontal therapy during the last 6 months.

Groups and intervention:

Patients selected in this study will be classified into two groups:

• Group 1: Fifteen patients will receive Phase I therapy; reevaluation after four weeks then will be treated with a placebo membrane

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

participants do not know the type of membrane and the outcomes assessor does not know type of group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Fifteen patients will receive Phase I therapy; reevaluation after four weeks then will be treated with a placebo membrane

Group Type PLACEBO_COMPARATOR

Ascorbic acid

Intervention Type DRUG

Ascorbic acid induce gingival healing

study group

Fifteen patients will receive Phase I therapy; reevaluation after four weeks then will be treated with membrane loaded by Ascorbic acid

Group Type ACTIVE_COMPARATOR

Ascorbic acid

Intervention Type DRUG

Ascorbic acid induce gingival healing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ascorbic acid

Ascorbic acid induce gingival healing

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients of both genders with ages more than 18 years.
2. At least two adjacent teeth in maxillary or mandibular anterior sextant with Cairo classification (RT1 or RT 2) labial GR defect.
3. Good general health with no contraindications for periodontal surgery (American Society of Anesthesiologists I).
4. Non-smoker patients.

Exclusion Criteria

1. Pregnant and lactating women.
2. Teeth exhibiting pathologic mobility.
3. Mal alignment teeth.
4. Patients under active orthodontic therapy.
5. Periodontal therapy during the last 6 months.
6. Patients received antibiotics or non-steroidal anti-inflammatory drugs six months before the beginning of the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No